293 related articles for article (PubMed ID: 14756579)
1. Safety and tolerability of lamotrigine for bipolar disorder.
Bowden CL; Asnis GM; Ginsberg LD; Bentley B; Leadbetter R; White R
Drug Saf; 2004; 27(3):173-84. PubMed ID: 14756579
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine: a review of its use in bipolar disorder.
Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
Drugs; 2003; 63(19):2029-50. PubMed ID: 12962521
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of lamotrigine: results from 12 placebo-controlled clinical trials and clinical implications.
Seo HJ; Chiesa A; Lee SJ; Patkar AA; Han C; Masand PS; Serretti A; Pae CU
Clin Neuropharmacol; 2011; 34(1):39-47. PubMed ID: 21242744
[TBL] [Abstract][Full Text] [Related]
4. Spotlight on lamotrigine in bipolar disorder.
Goldsmith DR; Wagstaff AJ; Ibbotson T; Perry CM
CNS Drugs; 2004; 18(1):63-7. PubMed ID: 14731061
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine for bipolar disorder: translating research into clinical practice.
Fung J; Mok H; Yatham LN
Expert Rev Neurother; 2004 May; 4(3):363-70. PubMed ID: 15853534
[TBL] [Abstract][Full Text] [Related]
6. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine for the treatment of bipolar disorder.
Engle PM; Heck AM
Ann Pharmacother; 2000 Feb; 34(2):258-62. PubMed ID: 10676836
[TBL] [Abstract][Full Text] [Related]
9. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder.
Calabrese JR; Bowden CL; McElroy SL; Cookson J; Andersen J; Keck PE; Rhodes L; Bolden-Watson C; Zhou J; Ascher JA
Am J Psychiatry; 1999 Jul; 156(7):1019-23. PubMed ID: 10401445
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine in the treatment of bipolar depression.
Bowden CL; Mitchell P; Suppes T
Eur Neuropsychopharmacol; 1999 Aug; 9 Suppl 4():S113-7. PubMed ID: 10524837
[TBL] [Abstract][Full Text] [Related]
12. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management.
Calabrese JR; Sullivan JR; Bowden CL; Suppes T; Goldberg JF; Sachs GS; Shelton MD; Goodwin FK; Frye MA; Kusumakar V
J Clin Psychiatry; 2002 Nov; 63(11):1012-9. PubMed ID: 12444815
[TBL] [Abstract][Full Text] [Related]
13. Clinical studies on the use of lamotrigine in bipolar disorder.
Calabrese JR; Rapport DJ; Shelton MD; Kujawa M; Kimmel SE
Neuropsychobiology; 1998 Oct; 38(3):185-91. PubMed ID: 9778607
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine in the treatment of bipolar disorder.
Bowden CL
Expert Opin Pharmacother; 2002 Oct; 3(10):1513-9. PubMed ID: 12387697
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine in mood disorders.
Green B
Curr Med Res Opin; 2003; 19(4):272-7. PubMed ID: 12841919
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine (Lamictal IR) for the treatment of bipolar disorder.
Bowden CL; Singh V
Expert Opin Pharmacother; 2012 Dec; 13(17):2565-71. PubMed ID: 23140205
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine: a review of clinical studies in bipolar disorders.
Zerjav-Lacombe S; Tabarsi E
Can J Psychiatry; 2001 May; 46(4):328-33. PubMed ID: 11387788
[TBL] [Abstract][Full Text] [Related]
18. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of lamotrigine for adults with bipolar disorder in a private practice setting.
Ginsberg LD
CNS Spectr; 2006 May; 11(5):376-82. PubMed ID: 16641842
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of mood-stabilising anticonvulsants in the elderly.
Fenn HH; Sommer BR; Ketter TA; Alldredge B
Expert Opin Drug Saf; 2006 May; 5(3):401-16. PubMed ID: 16610969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
